• Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Buy" by Analysts

    المصدر: Buzz FX / 06 يناير 2025 02:11:14   America/Chicago


    Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat January 6, 2025 Share Link copied to clipboard. Shares of Stoke Therapeutics, Inc. ( NASDAQ:STOK - Get Free Report ) have recei
    Read more...
شارك على،